Concepedia

Publication | Open Access

Efficacy and safety of infliximab and adalimumab in <scp>C</scp>rohn's disease: a single centre study

65

Citations

34

References

2012

Year

Abstract

Infliximab and adalimumab showed a similar efficacy. No smoking and non-stricturing non-penetrating behaviour were predictors of steroid-free remission.

References

YearCitations

Page 1